These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10319407)

  • 41. Overexpression of a DEAD box/RNA helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related chronic hepatitis and its implication in hepatocellular carcinogenesis.
    Miyaji K; Nakagawa Y; Matsumoto K; Yoshida H; Morikawa H; Hongou Y; Arisaka Y; Kojima H; Inoue T; Hirata I; Katsu K; Akao Y
    J Viral Hepat; 2003 Jul; 10(4):241-8. PubMed ID: 12823589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis.
    Murphy DM; Buckley PG; Bryan K; Watters KM; Koster J; van Sluis P; Molenaar J; Versteeg R; Stallings RL
    Mol Carcinog; 2011 Jun; 50(6):403-11. PubMed ID: 21557326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A human DEAD box protein with partial homology to heterogeneous nuclear ribonucleoprotein U.
    Godbout R; Hale M; Bisgrove D
    Gene; 1994 Jan; 138(1-2):243-5. PubMed ID: 8125309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
    Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of P27(KIP1) is prognostic and independent of MYCN amplification in human neuroblastoma.
    Bergmann E; Wanzel M; Weber A; Shin I; Christiansen H; Eilers M
    Int J Cancer; 2001 May; 95(3):176-83. PubMed ID: 11307151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA; Lazarova DL; Ross RA; Biedler JL
    Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
    BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Zimmerman MW; Liu Y; He S; Durbin AD; Abraham BJ; Easton J; Shao Y; Xu B; Zhu S; Zhang X; Li Z; Weichert-Leahey N; Young RA; Zhang J; Look AT
    Cancer Discov; 2018 Mar; 8(3):320-335. PubMed ID: 29284669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced MYCN oncogene expression in human neuroblastoma cells results in increased susceptibility to growth inhibition by TNF alpha.
    Schweigerer L; Scheurich P; Fotsis T
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1301-7. PubMed ID: 2202299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.
    Ikeda I; Ishizaka Y; Tahira T; Suzuki T; Onda M; Sugimura T; Nagao M
    Oncogene; 1990 Sep; 5(9):1291-6. PubMed ID: 2216455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
    Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
    Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells.
    Tanaka N; Fukuzawa M
    Int J Oncol; 2008 Oct; 33(4):815-21. PubMed ID: 18813796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification.
    Liu X; Mazanek P; Dam V; Wang Q; Zhao H; Guo R; Jagannathan J; Cnaan A; Maris JM; Hogarty MD
    Oncogene; 2008 Feb; 27(10):1478-88. PubMed ID: 17724465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma.
    Norris MD; Bordow SB; Haber PS; Marshall GM; Kavallaris M; Madafiglio J; Cohn SL; Salwen H; Schmidt ML; Hipfner DR; Cole SP; Deeley RG; Haber M
    Eur J Cancer; 1997 Oct; 33(12):1911-6. PubMed ID: 9516823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of rck/p54, a DEAD-box RNA helicase, in gametogenesis and early embryogenesis of mice.
    Matsumoto K; Kwon OY; Kim H; Akao Y
    Dev Dyn; 2005 Jul; 233(3):1149-56. PubMed ID: 15906376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization.
    Stock C; Bozsaky E; Watzinger F; Poetschger U; Orel L; Lion T; Kowalska A; Ambros PF
    Am J Pathol; 2008 Jan; 172(1):203-14. PubMed ID: 18165268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.
    Beckers A; Van Peer G; Carter DR; Mets E; Althoff K; Cheung BB; Schulte JH; Mestdagh P; Vandesompele J; Marshall GM; De Preter K; Speleman F
    Oncotarget; 2015 Mar; 6(7):5204-16. PubMed ID: 25294817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.
    O'Brien EM; Selfe JL; Martins AS; Walters ZS; Shipley JM
    BMC Cancer; 2018 Feb; 18(1):217. PubMed ID: 29466962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.